Skip to Main content Skip to Navigation
Journal articles

Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media

Abstract : Vero cells are nowadays widely used in the production of human vaccines. They are considered as one of the most productive and flexible continuous cell lines available for vaccine manufacturing. However, these cells are anchorage dependent, which greatly complicates upstream processing and process scale-up. Moreover, there is a recognized need to reduce the costs of vaccine manufacturing to develop vaccines that are affordable worldwide. The use of cell lines adapted to suspension growth contributes to reach this objective. The current work describes the adaptation of Vero cells to suspension culture in different serum free media according to multiple protocols based on subsequent passages. The best one that relies on cell adaption to IPT-AFM an in-house developed animal component free medium was then chosen for further studies. Besides, as aggregates have been observed, the improvement of IPT-AFM composition and mechanical dissociation were also investigated. In addition to IPT-AFM, three chemically defined media (CD293, Hycell CHO and CD-U5) and two serum free media (293SFMII and SFM4CHO) were tested to set up a serum free culture of the suspensionadapted Vero cells (VeroS) in shake flasks. Cell density levels higher than 2 Â 10 6 cells/mL were obtained in the assessed conditions. The results were comparable to those obtained in spinner culture of adherent Vero cells grown on Cytodex 1 microcarriers. Cell infection with LP-2061 rabies virus strain at an MOI (Multiplicity of Infection) of 0.1 and a cell density of 8 ± 0.5 Â 10 5 cells/mL resulted in a virus titer higher than 10 7 FFU/mL in all media tested. Nevertheless, the highest titer equal to 5.2 ± 0.5 Â 10 7 FFU/mL, was achieved in IPT-AFM containing a reduced amount of Ca ++ and Mg ++. Our results demonstrate the suitability of the obtained VeroS cells to produce rabies virus at a high titer, and pave the way to develop VeroS cells bioreactor process for rabies vaccine production.
Document type :
Journal articles
Complete list of metadata
Contributor : AbdelHakim Ben Hassine Connect in order to contact the contributor
Submitted on : Thursday, February 17, 2022 - 10:06:34 AM
Last modification on : Thursday, February 17, 2022 - 6:02:51 PM
Long-term archiving on: : Wednesday, May 18, 2022 - 6:30:19 PM


Publication funded by an institution


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License




Samia Rourou, Meriem Ben Zakkour, Héla Kallel. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Vaccine, Elsevier, 2019, 37 (47), pp.6987 - 6995. ⟨10.1016/j.vaccine.2019.05.092⟩. ⟨pasteur-03578194⟩



Record views


Files downloads